thiophenes has been researched along with Osteoarthritis in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.33) | 18.7374 |
1990's | 1 (2.33) | 18.2507 |
2000's | 6 (13.95) | 29.6817 |
2010's | 32 (74.42) | 24.3611 |
2020's | 3 (6.98) | 2.80 |
Authors | Studies |
---|---|
Chen, T; Chen, Y; Deng, Z; Gao, B; Gao, W; Huang, D; Li, P; Liang, A; Liang, T; Peng, Y; Qiu, J; Qiu, X; Su, P; Wang, X; Xu, C; Zhou, H; Zhu, Y | 1 |
Dai, Z; Felson, D; Lewis, CE; Lichtenstein, AH; Matthan, NR; Misra, D; Nevitt, M; Rabasa, G; Torner, J; Zertuche, JP | 1 |
Abrams, G; Adolfsson, E; Agarwal, PK; Akkan, AG; Al Alhareth, NS; Alves, VGL; Armentano, R; Bahroos, E; Baig, M; Baldridge, KK; Barman, S; Bartolucci, C; Basit, A; Bertoli, SV; Bian, L; Bigatti, G; Bobenko, AI; Boix, PP; Bokulic, T; Bolink, HJ; Borowiec, J; Bulski, W; Burciaga, J; Butt, NS; Cai, AL; Campos, AM; Cao, G; Cao, Y; Čapo, I; Caruso, ML; Chao, CT; Cheatum, CM; Chelminski, K; Chen, AJW; Chen, C; Chen, CH; Chen, D; Chen, G; Chen, H; Chen, LH; Chen, R; Chen, RX; Chen, X; Cherdtrakulkiat, R; Chirvony, VS; Cho, JG; Chu, K; Ciurlino, D; Coletta, S; Contaldo, G; Crispi, F; Cui, JF; D'Esposito, M; de Biase, S; Demir, B; Deng, W; Deng, Z; Di Pinto, F; Domenech-Ximenos, B; Dong, G; Drácz, L; Du, XJ; Duan, LJ; Duan, Y; Ekendahl, D; Fan, W; Fang, L; Feng, C; Followill, DS; Foreman, SC; Fortunato, G; Frew, R; Fu, M; Gaál, V; Ganzevoort, W; Gao, DM; Gao, X; Gao, ZW; Garcia-Alvarez, A; Garza, MS; Gauthier, L; Gazzaz, ZJ; Ge, RS; Geng, Y; Genovesi, S; Geoffroy, V; Georg, D; Gigli, GL; Gong, J; Gong, Q; Groeneveld, J; Guerra, V; Guo, Q; Guo, X; Güttinger, R; Guyo, U; Haldar, J; Han, DS; Han, S; Hao, W; Hayman, A; He, D; Heidari, A; Heller, S; Ho, CT; Ho, SL; Hong, SN; Hou, YJ; Hu, D; Hu, X; Hu, ZY; Huang, JW; Huang, KC; Huang, Q; Huang, T; Hwang, JK; Izewska, J; Jablonski, CL; Jameel, T; Jeong, HK; Ji, J; Jia, Z; Jiang, W; Jiang, Y; Kalumpha, M; Kang, JH; Kazantsev, P; Kazemier, BM; Kebede, B; Khan, SA; Kiss, J; Kohen, A; Kolbenheyer, E; Konai, MM; Koniarova, I; Kornblith, E; Krawetz, RJ; Kreouzis, T; Kry, SF; Laepple, T; Lalošević, D; Lan, Y; Lawung, R; Lechner, W; Lee, KH; Lee, YH; Leonard, C; Li, C; Li, CF; Li, CM; Li, F; Li, J; Li, L; Li, S; Li, X; Li, Y; Li, YB; Li, Z; Liang, C; Lin, J; Lin, XH; Ling, M; Link, TM; Liu, HH; Liu, J; Liu, M; Liu, W; Liu, YP; Lou, H; Lu, G; Lu, M; Lun, SM; Ma, Z; Mackensen, A; Majumdar, S; Martineau, C; Martínez-Pastor, JP; McQuaid, JR; Mehrabian, H; Meng, Y; Miao, T; Miljković, D; Mo, J; Mohamed, HSH; Mohtadi, M; Mol, BWJ; Moosavi, L; Mosdósi, B; Nabu, S; Nava, E; Ni, L; Novakovic-Agopian, T; Nyamunda, BC; Nyul, Z; Önal, B; Özen, D; Özyazgan, S; Pajkrt, E; Palazon, F; Park, HW; Patai, Á; Patai, ÁV; Patzke, GR; Payette, G; Pedoia, V; Peelen, MJCS; Pellitteri, G; Peng, J; Perea, RJ; Pérez-Del-Rey, D; Popović, DJ; Popović, JK; Popović, KJ; Posecion, L; Povall, J; Prachayasittikul, S; Prachayasittikul, V; Prat-González, S; Qi, B; Qu, B; Rakshit, S; Ravelli, ACJ; Ren, ZG; Rivera, SM; Salo, P; Samaddar, S; Samper, JLA; Samy El Gendy, NM; Schmitt, N; Sekerbayev, KS; Sepúlveda-Martínez, Á; Sessolo, M; Severi, S; Sha, Y; Shen, FF; Shen, X; Shen, Y; Singh, P; Sinthupoom, N; Siri, S; Sitges, M; Slovak, JE; Solymosi, N; Song, H; Song, J; Song, M; Spingler, B; Stewart, I; Su, BL; Su, JF; Suming, L; Sun, JX; Tantimavanich, S; Tashkandi, JM; Taurbayev, TI; Tedgren, AC; Tenhunen, M; Thwaites, DI; Tibrewala, R; Tomsejm, M; Triana, CA; Vakira, FM; Valdez, M; Valente, M; Valentini, AM; Van de Winckel, A; van der Lee, R; Varga, F; Varga, M; Villarino, NF; Villemur, R; Vinatha, SP; Vincenti, A; Voskamp, BJ; Wang, B; Wang, C; Wang, H; Wang, HT; Wang, J; Wang, M; Wang, N; Wang, NC; Wang, Q; Wang, S; Wang, X; Wang, Y; Wang, Z; Wen, N; Wesolowska, P; Willis, M; Wu, C; Wu, D; Wu, L; Wu, X; Wu, Z; Xia, JM; Xia, X; Xia, Y; Xiao, J; Xiao, Y; Xie, CL; Xie, LM; Xie, S; Xing, Z; Xu, C; Xu, J; Yan, D; Yan, K; Yang, S; Yang, X; Yang, XW; Ye, M; Yin, Z; Yoon, N; Yoon, Y; Yu, H; Yu, K; Yu, ZY; Zhang, B; Zhang, GY; Zhang, H; Zhang, J; Zhang, M; Zhang, Q; Zhang, S; Zhang, W; Zhang, X; Zhang, Y; Zhang, YW; Zhang, Z; Zhao, D; Zhao, F; Zhao, P; Zhao, W; Zhao, Z; Zheng, C; Zhi, D; Zhou, C; Zhou, FY; Zhu, D; Zhu, J; Zhu, Q; Zinyama, NP; Zou, M; Zou, Z | 1 |
Chu, X; Huang, X; Ma, X; Ni, B; Tan, G; Xi, Y; You, H; Zhang, R | 1 |
Bonfim, BF; Cartágenes, MSS; Freire, AO; Garcia, JBS; Rodrigues, TA | 1 |
Bay-Jensen, AC; Hägglund, P; Karsdal, MA; Kayed, A; Kjelgaard-Petersen, CF; Mobasheri, A; Sharma, N; Thudium, CS | 1 |
Bhatti, FUR; Cho, H; Hasty, KA | 1 |
Andrews, JS; Bansal, M; Happich, M; Klein, RW; Wielage, RC | 2 |
Cai, N; Moore, RA; Skljarevski, V; Tölle, TR | 1 |
Andrews, JS; Chen, SY; Novick, D; Peng, X; Wu, N; Yu, X | 1 |
Henske, R; Liedgens, H | 1 |
Gahn, J; Han, B; Happich, M; Myers, J; Paget, MA; Price, K; Wielage, RC | 1 |
Cheleschi, S; Fioravanti, A; Galeazzi, M; Guidelli, GM; Tenti, S | 1 |
Bansal, M; Happich, M; Klein, RW; Lee, S; Patel, AJ; Wielage, RC | 1 |
Ishikawa, G; Nagakura, Y; Shimizu, Y; Takeshita, N | 1 |
Dai, M; Tian, F; Wang, Y; Zhang, L | 1 |
da Silva Junior, FS; de Melo Leite, AC; de Melo Nunes, R; de Queiroz Cunha, F; Girão, VC; Marinho, AL; Martins, MR; Pinto, AC; Rocha, FA | 1 |
Ding, C; Hunter, DJ; Wang, K; Xu, J | 1 |
Sharma, L | 1 |
Bai, X; Ding, C; Fan, S; Han, W | 1 |
Chu, JG; Dai, MW; Shao, LT; Song, HP; Tian, FM; Wang, Y; Xiao, YP; Zhang, L; Zhang, YZ | 1 |
Bentley, S; Fan, MY; Gardner, G; Sullivan, MD | 1 |
Bruyere, O; Hiligsmann, M; Neuprez, A; Reginster, JY; Scholtissen, S | 1 |
Bruyère, O; Burlet, N; Cooper, C; Delmas, PD; Reginster, JY; Rizzoli, R | 1 |
Bennett, RM; Chappell, AS; Collins, H; Iyengar, S; Li, LC; Liu-Seifert, H; Ossanna, MJ; Skljarevski, V | 1 |
Alexandersen, P; Byrjalsen, I; Christiansen, C; Karsdal, MA | 1 |
Marcus, DA | 1 |
Caron, J; Martel-Pelletier, J; Mineau, F; Pelletier, JP; Tat, SK | 1 |
Citrome, L; Weiss-Citrome, A | 2 |
Doschak, MR; Maksymowych, WP; Panahifar, A | 1 |
Langley, P; Nalamachu, S; Pergolizzi, JV; Raffa, RB; Rodriguez, G; Taylor, R | 1 |
Blesius, A; Fahmi, H; Kapoor, M; Lajeunesse, D; Maillet, J; Martel-Pelletier, J; Pelletier, JP | 1 |
Bansal, M; Happich, M; Klein, R; Wielage, R; Wilson, K | 1 |
Lafeber, FP; van Laar, JM | 1 |
Ding, HF; Li, Y; Liu, GW; Liu, M; Liu, S; Mao, YQ; Nie, SB; Wang, XQ; Yu, B; Yu, DG; Zhao, X; Zhu, ZA | 1 |
Lluch Girbés, E; López Cubas, C; Nijs, J; Torres-Cueco, R | 1 |
Kendler, D | 1 |
Adami, S; Brixen, K; Bruyere, O; Delferriere, D; Devogelaer, JP; Fechtenbaum, J; Kolta, S; Reginster, JY; Roux, C; Spector, T; Wark, JD | 1 |
Thornton, EJ; Walter, J; Wojtulewski, J | 1 |
Crone, H; Forsskåhl, B; Hamberg, P; Harilainen, A; Sandelin, J; Tamelander, G | 1 |
14 review(s) available for thiophenes and Osteoarthritis
Article | Year |
---|---|
Topics: Acetylcholine; Acinetobacter baumannii; Actinobacteria; Action Potentials; Adalimumab; Adaptation, Physiological; Adipates; Administration, Oral; Adolescent; Adrenal Glands; Adsorption; Adult; Aged; Aged, 80 and over; Aging; AIDS-Related Opportunistic Infections; Aldosterone; Amino Acids; Ammonia; Amoxicillin; AMP-Activated Protein Kinases; Animals; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Antirheumatic Agents; Apgar Score; Area Under Curve; ARNTL Transcription Factors; Arterial Pressure; Arthritis, Juvenile; Athletes; Attention; Biodegradation, Environmental; Biofilms; Biofuels; Biological Therapy; Biomass; Biomimetic Materials; Bioreactors; Birth Weight; Bismuth; Blood Flow Velocity; Bone and Bones; Brain Injuries, Traumatic; Calcium; Calcium Channels; Capsaicin; Carbon; Carcinoma, Hepatocellular; Cardiomegaly, Exercise-Induced; Cartilage; Cartilage, Articular; Case-Control Studies; Catalysis; Cats; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Death; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Charcoal; Chemokine CCL2; Child; Child, Preschool; Chondrogenesis; Chronic Disease; Circadian Clocks; Circadian Rhythm Signaling Peptides and Proteins; Clarithromycin; Coccidioides; Coccidioidomycosis; Cognitive Behavioral Therapy; Coinfection; Color; Coloring Agents; Computer Simulation; Computers, Molecular; Consensus; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cytochrome P-450 Enzyme System; Death, Sudden, Cardiac; Density Functional Theory; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dialysis Solutions; Disease Models, Animal; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Electrocardiography; Electrocardiography, Ambulatory; Electrolytes; Endocardium; Endocrine Disruptors; Endocytosis; Endoscopy, Gastrointestinal; Escherichia coli Proteins; Esters; Evolution, Molecular; Executive Function; Feasibility Studies; Female; Ferric Compounds; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; Frailty; Free Radical Scavengers; Gabapentin; Geriatric Assessment; Glucaric Acid; Glucocorticoids; Glucose; Glucose Metabolism Disorders; Halogenated Diphenyl Ethers; Heart Rate; Heart Ventricles; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hep G2 Cells; Hepatocytes; Humans; Hungary; Hydrogen Sulfide; Hydrogen-Ion Concentration; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Independent Living; Indocyanine Green; Infant; Infant Formula; Infant Mortality; Infant, Newborn; Infant, Newborn, Diseases; Inflorescence; Insulin Resistance; Insulins; International Agencies; Iron; Isotonic Solutions; Kidney Failure, Chronic; Kinetics; Lactones; Leukocytes, Mononuclear; Liver Neoplasms; Macular Edema; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetosomes; Male; Medical Audit; Mesenchymal Stem Cells; Metabolic Syndrome; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Middle Aged; Molecular Conformation; Molecular Targeted Therapy; Motor Activity; Multiple Sclerosis; Mycophenolic Acid; Netherlands; Neuropsychological Tests; Nuclear Energy; Organs at Risk; Osteoarthritis; Osteoarthritis, Hip; Oxidation-Reduction; Palladium; Pericardium; Perinatal Death; Peritoneal Dialysis; Phantoms, Imaging; Pharmaceutical Preparations; Phospholipids; Phosphorylation; Physical Conditioning, Human; Physical Endurance; Pilot Projects; Polyketides; Polymers; Positron-Emission Tomography; Postoperative Period; Potassium; Powders; Pramipexole; Predictive Value of Tests; Pregabalin; Pregnancy; Pregnancy Outcome; Protein Structure, Secondary; Proton Pump Inhibitors; Puberty; Pulmonary Circulation; Quality Assurance, Health Care; Quantum Dots; Radiometry; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Rats, Sprague-Dawley; Receptors, CCR2; Receptors, Transferrin; Regeneration; Registries; Renal Insufficiency, Chronic; Reproducibility of Results; Research Design; Restless Legs Syndrome; Retina; Retinoid X Receptor alpha; Retrospective Studies; Rhenium; Risk Factors; RNA, Messenger; Severity of Illness Index; Sex Factors; Sodium; Sodium Fluoride; Solvents; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Stroke; Structure-Activity Relationship; Tachycardia, Ventricular; Tetracycline; Tetrahydrofolate Dehydrogenase; Tetrahydronaphthalenes; Thermodynamics; Thiophenes; Time Factors; Tinidazole; Tomography, Optical Coherence; Tomography, X-Ray Computed; Topiramate; Toxoplasma; Toxoplasmosis, Cerebral; Transferrin; Treatment Outcome; Up-Regulation; Upper Extremity; Uremia; Uveitis; Vascular Remodeling; Ventricular Fibrillation; Ventricular Function, Left; Ventricular Function, Right; Ventricular Remodeling; Verapamil; Veterans; Visual Acuity; Vitrectomy; Water Pollutants, Chemical; Zea mays; Zirconium | 2019 |
Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review.
Topics: Animals; Arthralgia; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Cartilage, Articular; Disease Progression; Humans; Osteoarthritis; Thiophenes | 2018 |
The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis.
Topics: Acetaminophen; Administration, Oral; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Bayes Theorem; Drug Evaluation; Duloxetine Hydrochloride; Etoricoxib; Humans; Narcotics; Osteoarthritis; Pain Measurement; Pyridines; Sulfones; Thiophenes; Treatment Outcome | 2014 |
What about strontium ranelate in osteoarthritis? Doubts and securities.
Topics: Bone Density Conservation Agents; Disease Progression; Humans; Joints; Osteoarthritis; Thiophenes; Treatment Outcome | 2014 |
Drugs for osteoarthritis.
Topics: Acetaminophen; Adrenal Cortex Hormones; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Capsaicin; Chondroitin; Dietary Supplements; Duloxetine Hydrochloride; Glucosamine; Humans; Hyaluronic Acid; Injections, Intra-Articular; Osteoarthritis; Thiophenes; Tramadol | 2014 |
[Research progress of effects of strontium ranelate on osteoarthritis].
Topics: Bone and Bones; Bone Density Conservation Agents; Cartilage, Articular; Disease Progression; Humans; Organometallic Compounds; Osteoarthritis; Osteoblasts; Osteoclasts; Thiophenes | 2014 |
Investigational drugs for the treatment of osteoarthritis.
Topics: Animals; Bone Density Conservation Agents; Disease Progression; Drug Design; Drugs, Investigational; Humans; Osteoarthritis; Pain; Thiophenes | 2015 |
Osteoarthritis year in review 2015: clinical.
Topics: Adalimumab; Antirheumatic Agents; Arthroplasty, Replacement; Bone Density Conservation Agents; Chondroitin Sulfates; Cognitive Behavioral Therapy; Diphosphonates; Exercise Therapy; Glucosamine; Humans; Methotrexate; Osteoarthritis; Physical Therapy Modalities; Resistance Training; Thiophenes; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; Ultrasonic Therapy | 2016 |
Strontium ranelate, a promising disease modifying osteoarthritis drug.
Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Disease Progression; Dose-Response Relationship, Drug; Humans; Osteoarthritis; Osteoarthritis, Knee; Thiophenes | 2017 |
Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Female; Fractures, Bone; Humans; Medication Adherence; Organometallic Compounds; Osteoarthritis; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic; Thiophenes | 2008 |
Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
Topics: Anthraquinones; Antirheumatic Agents; Calcitonin; Chondroitin Sulfates; Clinical Trials as Topic; Etidronic Acid; Glucosamine; Humans; Hyaluronic Acid; Organometallic Compounds; Osteoarthritis; Outcome Assessment, Health Care; Plant Extracts; Risedronic Acid; Thiophenes | 2008 |
A systematic review of duloxetine for osteoarthritic pain: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Topics: Chronic Pain; Duloxetine Hydrochloride; Humans; Musculoskeletal Pain; Osteoarthritis; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2012 |
A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
Topics: Analgesics; Chronic Pain; Diabetic Neuropathies; Duloxetine Hydrochloride; Fibromyalgia; Humans; Low Back Pain; Musculoskeletal Pain; Osteoarthritis; Thiophenes | 2013 |
Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective.
Topics: Age Factors; Aged; Amitriptyline; Analgesics; Cardiovascular Diseases; Celecoxib; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Gastrointestinal Diseases; Humans; Hydromorphone; Low Back Pain; Markov Chains; Middle Aged; Models, Economic; Naproxen; Ontario; Osteoarthritis; Outcome Assessment, Health Care; Oxycodone; Pregabalin; Pyrazoles; Quality-Adjusted Life Years; Quebec; Sulfonamides; Thiophenes | 2013 |
8 trial(s) available for thiophenes and Osteoarthritis
Article | Year |
---|---|
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
Topics: Antidepressive Agents; Chronic Pain; Diabetic Neuropathies; Double-Blind Method; Duloxetine Hydrochloride; Fibromyalgia; Humans; Individuality; Low Back Pain; Osteoarthritis; Pain Measurement; Thiophenes; Treatment Outcome | 2014 |
Utilization of duloxetine and celecoxib in osteoarthritis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Celecoxib; Cyclooxygenase 2 Inhibitors; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Osteoarthritis; Pyrazoles; Retrospective Studies; Sulfonamides; Thiophenes | 2013 |
A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain; Pain Measurement; Single-Blind Method; Thiophenes; Time Factors; Treatment Outcome | 2009 |
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
Topics: Aged; Analgesics; Antidepressive Agents; Depression; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Knee; Male; Middle Aged; Osteoarthritis; Pain; Pain Measurement; Psychiatric Status Rating Scales; Thiophenes; Treatment Outcome | 2009 |
Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis.
Topics: Aged; Biomarkers; Bone Density Conservation Agents; Collagen Type I; Creatinine; Female; Humans; Organometallic Compounds; Osteoarthritis; Osteoporosis; Peptides; Postmenopause; Thiophenes | 2011 |
Effects of strontium ranelate on spinal osteoarthritis progression.
Topics: Aged; Back Pain; Bone Density Conservation Agents; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Osteoarthritis; Osteoporosis, Postmenopausal; Severity of Illness Index; Spinal Diseases; Thiophenes; Treatment Outcome | 2008 |
Tiaprofenic acid (surgam) in the treatment of osteoarthritis of the knee and hip.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Hip Joint; Humans; Indomethacin; Knee Joint; Middle Aged; Osteoarthritis; Propionates; Random Allocation; Thiophenes | 1981 |
Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel.
Topics: Administration, Oral; Administration, Topical; Aniline Compounds; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Knee Joint; Male; Osteoarthritis; Thiophenes | 1997 |
21 other study(ies) available for thiophenes and Osteoarthritis
Article | Year |
---|---|
Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway.
Topics: Aged; Animals; Base Sequence; Benzamides; Cartilage, Articular; Chondrocytes; Disease Models, Animal; Down-Regulation; Female; Fluorocarbons; Humans; Interleukin-6; Male; Mice, Inbred C57BL; Models, Biological; Nuclear Receptor Subfamily 1, Group F, Member 1; Osteoarthritis; Phosphorylation; Promoter Regions, Genetic; RNA, Messenger; Severity of Illness Index; Signal Transduction; STAT3 Transcription Factor; Sulfonamides; Thiophenes | 2021 |
Alkylresorcinol, a biomarker for whole grain intake, and its association with osteoarthritis: the MOST study.
Topics: Biomarkers; Female; Humans; Imidazoles; Knee Joint; Male; Osteoarthritis; Osteoarthritis, Knee; Sulfonamides; Thiophenes; Whole Grains | 2022 |
Protective effects of Erdosteine on interleukin-1β-stimulated inflammation via inhibiting the activation of MAPK, NF-κB, and Wnt/β-catenin signaling pathways in rat osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Cells, Cultured; Chondrocytes; Dose-Response Relationship, Drug; Extracellular Matrix; Inflammation; Injections, Intra-Articular; Interleukin-1beta; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoarthritis; Rats; Rats, Sprague-Dawley; Signal Transduction; Thioglycolates; Thiophenes; Wnt Signaling Pathway | 2020 |
Tofacitinib and TPCA-1 exert chondroprotective effects on extracellular matrix turnover in bovine articular cartilage ex vivo.
Topics: Amides; Animals; Cartilage, Articular; Cattle; Chondrocytes; Collagen Type II; Extracellular Matrix Proteins; Imidazoles; Osteoarthritis; Oxazines; Piperidines; Proteoglycans; Pyridines; Pyrimidines; Pyrroles; Thiophenes | 2019 |
Anti-inflammatory role of TPCA-1 encapsulated nanosomes in porcine chondrocytes against TNF-α stimulation.
Topics: Amides; Animals; Anti-Inflammatory Agents; Basic Helix-Loop-Helix Transcription Factors; Chondrocytes; Collagen Type II; Down-Regulation; Drug Delivery Systems; Gene Expression; Inflammation; Matrix Metalloproteinase 13; Osteoarthritis; Signal Transduction; Swine; Thiophenes; Tumor Necrosis Factor-alpha | 2019 |
Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Chronic Pain; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Osteoarthritis; Prescription Fees; Thiophenes; United States | 2013 |
Authors' reply to Liedgens and Henske: "cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective".
Topics: Female; Humans; Male; Markov Chains; Models, Economic; Osteoarthritis; Thiophenes | 2013 |
Comment on: "cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective".
Topics: Female; Humans; Male; Markov Chains; Models, Economic; Osteoarthritis; Thiophenes | 2013 |
Cost effectiveness of duloxetine for osteoarthritis: a Quebec societal perspective.
Topics: Analgesics; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Cost-Benefit Analysis; Duloxetine Hydrochloride; Female; Humans; Male; Markov Chains; Middle Aged; Osteoarthritis; Quebec; Socioeconomic Factors; Thiophenes | 2014 |
Efficacy of drugs with different mechanisms of action in relieving spontaneous pain at rest and during movement in a rat model of osteoarthritis.
Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Duloxetine Hydrochloride; Gait; Iodoacetic Acid; Male; Morphine; Movement; Osteoarthritis; Pain; Rats; Rest; Thiophenes; Tramadol; Weight-Bearing | 2014 |
Strontium ranelate analgesia in arthritis models is associated to decreased cytokine release and opioid-dependent mechanisms.
Topics: Analgesics, Non-Narcotic; Animals; Arthralgia; Chemokine CXCL1; Cytokines; Dose-Response Relationship, Drug; Injections, Intra-Articular; Interleukin-1beta; Joints; Naloxone; Narcotic Antagonists; Osteoarthritis; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid; Thiophenes; Tumor Necrosis Factor-alpha | 2015 |
Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis.
Topics: Animals; Bone Density Conservation Agents; Disease Models, Animal; Guinea Pigs; Male; Osteoarthritis; Osteophyte; Thiophenes | 2017 |
Duloxetine use in painful conditions.
Topics: Analgesia; Analgesics; Animals; Antidepressive Agents; Chronic Disease; Disease Models, Animal; Duloxetine Hydrochloride; Humans; Low Back Pain; Osteoarthritis; Pain; Retrospective Studies; Thiophenes; Treatment Outcome | 2011 |
Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Topics: Adult; Aged; Aged, 80 and over; Animals; Bone Density Conservation Agents; Bone Remodeling; Bone Resorption; Cells, Cultured; Female; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Organometallic Compounds; Osteoarthritis; Osteoblasts; Protein Isoforms; RANK Ligand; Thiophenes | 2011 |
Antidepressants and the relief of osteoarthritic pain - findings from a study examining adjunctive duloxetine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Chronic Pain; Drug Combinations; Duloxetine Hydrochloride; Humans; Musculoskeletal Pain; Osteoarthritis; Thiophenes; Treatment Outcome | 2012 |
Potential mechanism of alendronate inhibition of osteophyte formation in the rat model of post-traumatic osteoarthritis: evaluation of elemental strontium as a molecular tracer of bone formation.
Topics: Alendronate; Animals; Arthritis, Experimental; Bone Density Conservation Agents; Drug Evaluation, Preclinical; Electron Probe Microanalysis; Female; Organometallic Compounds; Osteoarthritis; Osteogenesis; Osteophyte; Rats; Rats, Sprague-Dawley; Thiophenes; Tibial Meniscus Injuries; X-Ray Microtomography | 2012 |
Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium.
Topics: Animals; Antirheumatic Agents; Cartilage, Articular; Disease Models, Animal; Disease Progression; Dogs; Female; Gene Expression; Interleukin-1beta; Organometallic Compounds; Osteoarthritis; Peptide Hydrolases; Real-Time Polymerase Chain Reaction; Synovial Membrane; Thiophenes | 2013 |
Strontium ranelate: ready for clinical use as disease-modifying osteoarthritis drug?
Topics: Animals; Antirheumatic Agents; Humans; Organometallic Compounds; Osteoarthritis; Thiophenes | 2013 |
Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Bone Remodeling; Chondrocytes; Disease Models, Animal; Dose-Response Relationship, Drug; Immunohistochemistry; In Situ Nick-End Labeling; Male; Menisci, Tibial; Osteoarthritis; Rats; Rats, Sprague-Dawley; SOX9 Transcription Factor; Spectrum Analysis, Raman; Thiophenes; Tibial Meniscus Injuries; Time Factors | 2013 |
Pain treatment for patients with osteoarthritis and central sensitization.
Topics: Brain Mapping; Cognitive Behavioral Therapy; Duloxetine Hydrochloride; Exercise Therapy; Humans; Hyperalgesia; Magnetic Resonance Imaging; Neuralgia; Neuroglia; Nociception; Osteoarthritis; Pain Management; Physical Therapy Modalities; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2013 |
Boning up on osteoporosis--current thinking on management. Interview by Emma Buchanan.
Topics: Accidental Falls; Age Factors; Bone Density Conservation Agents; Diphosphonates; Humans; Organometallic Compounds; Osteoarthritis; Raloxifene Hydrochloride; Teriparatide; Thiophenes | 2006 |